Polen Thomas E Jr sold $629K of BDX
Polen Thomas E Jr (Chairman, CEO and President) sold 2,993 shares of BECTON DICKINSON & CO (BDX) at $210.00 ($0.63M total) on 2026-11-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds transparency but is unlikely to move the stock materially.
Market read
A modest insider sale; traders may note but not act on it.
What to watch
Potential upcoming earnings or product announcements may outweigh the sale's effect.
Background
SEC Form 4 filing discloses an insider transaction by Becton Dickinson's CEO.
Ticker impact
CEO Thomas E. Polen Jr sold 2,993 BDX shares for $628,530 via a 10b5‑1 plan, reducing his stake to 110,163 shares.
likely slight downward pressure as the market prices in the insider sale
A $628k sale by the CEO is a routine 10b5‑1 transaction; while not large, it signals potential insider sentiment and can prompt short‑term weakness.
Market effects
Minimal impact on the healthcare equipment sector.
No significant regional effect.
Limited to BDX investors.
Counterpoint
The sale could be a routine liquidity event and not indicative of negative outlook.
Key entities
- companyBecton Dickinson & Co.
Medical technology and device manufacturer.
- personThomas E. Polen Jr
Chairman, CEO and President of Becton Dickinson.




